Stay updated on Psoriasis Treatment Efficacy in Clinical Trial
Sign up to get notified when there's something new on the Psoriasis Treatment Efficacy in Clinical Trial page.

Latest updates to the Psoriasis Treatment Efficacy in Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew Revision: v3.3.4 appears on the page, replacing the prior Revision: v3.3.3. This is a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe study’s Locations section was expanded to include additional sites across the United States and Canada (e.g., CA, CO, CT, FL, IL, IN, IA, KY, MA, MI, NE, NV, NH, NJ, NM, NY, NC, OR, PA, SC, TX, UT and Canadian provinces). The Revision is updated from v3.3.2 to v3.3.3, and the HHS Vulnerability Disclosure entry was removed.SummaryDifference1%

- Check58 days agoChange DetectedPublications section wording updated to reflect automatic PubMed population of publications; revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check66 days agoChange DetectedRemoved the government funding status notice from the page. The study details, eligibility criteria, and outcome measures remain unchanged.SummaryDifference0.2%

- Check87 days agoChange DetectedNo significant changes detected; the page content and location listings appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check109 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference1%

Stay in the know with updates to Psoriasis Treatment Efficacy in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psoriasis Treatment Efficacy in Clinical Trial page.